Novartis
We serve as adherence subject matter experts to Novartis Digital Medicines. In this capacity, we help:
- identify treatments that are unforgiving to poor adherence
- determine patients or patient demographics that have particular issues with medication adherence
- match those treatments and those patients with adherence technologies or digital solutions that can address these adherence challenges, enhance patient care, and improve health outcomes
Client
Novartis Digital Medicines
Year
2017 – Present
Services
- Served as Adherence Subject Matter Expert
- Advisory services related digital health technologies and technology-enabled patient care
Our understanding of the human organism, in both health and disease, is exceptionally primitive. It requires a strange combination of audacity and foolhardiness to believe you can create a product that will impact disease in a meaningful way. We need to bring our best technology — biological and digital — and our most creative people together to work on this monumental challenge.